antibacterial drug

ChEBI CHEBI:36047
Associated conditions

Datasets

Papers Phenotype Conditions Collection Tested mutants Data Details
Chan TF~Zheng XF, 2000 growth (streaks on agar) rapamycin [25 nM] hap a ~2,216 Discrete
Alamgir M~Golshani A, 2010 growth (colony size) streptomycin [40 mg/ml] hap a 4,669 Quantitative
Xie MW~Huang J, 2005 growth (colony size) rapamycin [10 nM] hap a/het 5,784 Quantitative
Xie MW~Huang J, 2005 growth (colony size) rapamycin [30 nM] hap a/het 5,784 Quantitative
Blackburn AS~Avery SV, 2003 growth (MIC) amoxicillin [256 ug/ml] hap a ~4,800 Discrete
Alamgir M~Golshani A, 2008 growth (colony size) paromomycin [13 mg/ml] hap a 4,669 Quantitative
Blackburn AS~Avery SV, 2003 growth (MIC) penicillin G [256 ug/ml] hap a ~4,800 Discrete
Blackburn AS~Avery SV, 2003 growth (MIC) oxytetracyclin [256 ug/ml] hap a ~4,800 Discrete
Blackburn AS~Avery SV, 2003 growth (MIC) tetracycline [256 ug/ml] hap a ~4,800 Discrete
Blackburn AS~Avery SV, 2003 growth (MIC) vancomycin [256 ug/ml] hap a ~4,800 Discrete
Parsons AB~Boone C, 2004 growth (colony size) rapamycin [0.015 ug/ml] hap a ~4,700 Discrete
Neklesa TK~Davis RW, 2008 growth (relative abundance in pooled culture) rapamycin [7.5 ng/ml] hom ~4,757 Discrete
Parsons AB~Boone C, 2006 growth (relative abundance in pooled culture) Doxycycline hyclate [1.12 mM] hap a 4,111 Quantitative
Parsons AB~Boone C, 2006 growth (relative abundance in pooled culture) rapamycin [5.5 pM] hap a 4,111 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) rapamycin [4.88 nM], time [overnight + 20 generations] hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [overnight + 20 generations], rapamycin [5 nM] hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) rapamycin [6 nM], time [overnight + 20 generations] hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) rapamycin [9 nM], time [5 generations] hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [overnight + 10 generations], rapamycin [9 nM] hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [overnight + 5 generations], rapamycin [9 nM] hom 4,742 Quantitative
Hoepfner D~Movva NR, 2014 growth (relative abundance in pooled culture) rapamycin [1 nM] hom 4,516 Quantitative
Hoepfner D~Movva NR, 2014 growth (relative abundance in pooled culture) rapamycin [0.2 nM] hom 4,516 Quantitative
Hoepfner D~Movva NR, 2014 growth (relative abundance in pooled culture) rapamycin [0.5 nM] hom 4,516 Quantitative
Hoepfner D~Movva NR, 2014 growth (relative abundance in pooled culture) rapamycin [0.8 nM] hom 4,516 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) josamycin [24.20 uM] hom 4,810 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) rapamycin [4.00 nM] hom 4,810 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) rapamycin [2.00 nM] hom 4,810 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) rapamycin [362.00 pM] hom 4,810 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) benzyl isothiocyanate [8.31 uM] hom 4,810 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) rapamycin [1.00 nM] hom 4,810 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) sertaconazole [140.00 nM] hom 4,810 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) oxolinic acid [75.00 uM] hom 4,810 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) fumagillin [50.00 uM] hom 4,810 Quantitative
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) minimal complete [standard], doxycycline [400 ug/ml] het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) minimal complete [standard], nalidixic acid [325 ug/ml] het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) nitrofurantoin [500 ug/ml], minimal complete [standard] het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) minimal complete [standard], paromomycin [5 mg/ml] het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) minimal complete [standard], tetracycline [800 ug/ml] het 3,503 Quantitative only for hits
Dudley AM~Church GM, 2005 growth (spot assay) rapamycin [0.1 ug/ml] hom 4,621 Discrete
Neklesa TK~Davis RW, 2009 protein activity rapamycin [20ng/ml] hom/het? ~5,100 Discrete
Hoepfner D~Movva NR, 2014 growth (relative abundance in pooled culture) rapamycin [0.2 nM] het 5,782 Quantitative
Hoepfner D~Movva NR, 2014 growth (relative abundance in pooled culture) rapamycin [0.5 nM] het 5,782 Quantitative
Hoepfner D~Movva NR, 2014 growth (relative abundance in pooled culture) rapamycin [0.8 nM] het 5,782 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) rapamycin [4.88 nM], time [overnight + 20 generations] het 5,686 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [overnight + 20 generations], rapamycin [5 nM] het 5,686 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) rapamycin [6 nM], time [overnight + 20 generations] het 5,686 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [overnight + 20 generations], nalidixic acid [1 mM] het 5,720 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [overnight + 20 generations], paromomycin sulfate [500 uM] het 5,720 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) rapamycin [9 nM], time [overnight + 20 generations] het 5,686 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [overnight + 20 generations], thiram [15.6 uM] het 5,720 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) rapamycin [362.00 pM] het 855 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) benzyl isothiocyanate [8.31 uM] het 839 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) rapamycin [1.00 nM] het 818 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) josamycin [24.20 uM] het 883 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) rapamycin [4.00 nM] het 881 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) rapamycin [2.00 nM] het 880 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) sertaconazole [140.00 nM] het 815 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) oxolinic acid [75.00 uM] het 1,016 Quantitative
Lee AY~Giaever G, 2014 growth (relative abundance in pooled culture) fumagillin [50.00 uM] het 1,016 Quantitative